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Background: Estrogen-related receptors (ERRs) are orphan nuclear hormone receptors expressed in metabolically
active tissues and modulate numerous homeostatic processes. ERRs do not bind the ligand estrogen, but they are
able to bind the estrogen response element (ERE) embedded within the ERR response elements (ERREs) to regulate
transcription of genes. Previous work has demonstrated that adult mice lacking Errβ have altered metabolism and
meal patterns. To further understand the biological role of Errβ, we characterized the stress response of mice
deficient for one or both alleles of Errβ.
Results: Sox2-Cre:Errβ mice lack Errβ expression in all tissues of the developing embryo. Sox2-Cre:Errβ+/lox
heterozygotes were obese, had increased Npy and Agrp gene expression in the arcuate nucleus of the
hypothalamus, and secreted more corticosterone in response to stress. In contrast, Sox2-Cre:Errβlox/lox homozygotes
were lean and, despite increased Npy and Agrp gene expression, did not secrete more corticosterone in response
to stress. Sox2-Cre:Errβ+/lox and Sox2-Cre:Errβlox/lox mice treated with the Errβ and Errγ agonist DY131 demonstrated
increased corticotropin-releasing hormone (Crh) expression in the paraventricular nucleus of the hypothalamus,
although corticosterone levels were not affected. Nes-Cre:Errβlox/lox mice, which selectively lack Errβ expression in the
nervous system, also demonstrated elevated stress response during an acoustic startle response test and decreased
expression of both Crh and corticotropin-releasing hormone receptor 2 (Crhr2).
Conclusions: Loss of Errβ affects body composition, neuropeptide levels, stress hormones, and centrally-modulated
startle responses of mice. These results indicate that Errβ alters the function of the hypothalamic-pituitary-adrenocortical
axis and indicates a role for Errβ in regulating stress response.Background
ERRs are nuclear hormone receptors that regulate multiple
homeostatic processes throughout life [1]. ERRs were ini-
tially identified on the basis of sequence homology to es-
trogen receptors (ERs) [2]. The homology between Errs
and Ers is 36% in the ligand binding domain and 68% in
the DNA binding domain. ERRs bind both ERR response
elements (ERREs) and the closely related estrogen response
elements (EREs) embedded within an ERRE sequence on
DNA to modulate transcription of target genes [3-8]. Errs
activate gene transcription by binding to DNA, either as a
monomer, homodimer, or a heterodimer complex, which
includes two different Err isoforms [1,6,7,9,10]. While their* Correspondence: mardibyerly@gmail.com
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reproduction in any medium, provided the orbinding sites are similar to those of Ers, Errs do not bind
estradiol and instead activate transcription in a ligand-
independent manner, leading to their classification as or-
phan nuclear receptors. The three different Err genes, α, β
and γ, have highly conserved ligand and DNA binding do-
mains and thus may regulate homeostatic processes in a
compensatory manner [11].
In mice, Errβ and Errγ are selectively expressed in the
brain and multiple peripheral tissues [2,12-14] and share
the highest degree of sequence homology [11], suggesting
that they may share overlapping functions. Since Errs
recognize the same response elements, they are likely to
regulate overlapping subsets of target genes [11].
We have previously reported that whole-body or cen-
tral nervous system-specific deletion of Errβ increases
expression of Errγ and ultimately alters body compos-
ition, metabolism, meal patterns, and energy expenditure
of mice [11]. Further, inhibition of Errβ or Errγ altertd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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body composition, food intake and neuropeptide expres-
sion), while deletion of Errβ reciprocally modulates ex-
pression of Errγ (and vice versa) suggesting that balanced
expression of Errβ and Errγ is important for control of en-
ergy balance and food intake [14-18].
Alterations in glucocorticoid signaling and whole-body
energy balance positively correlate with one another,
with increased glucocorticoid levels resulting in in-
creased body weight [19-21]. Errβ suppresses gluco-
corticoid receptor activity in neuroblastoma and kidney
cells in a dose-dependent manner, suggesting that it may
also regulate metabolism at least in part through modula-
tion of the hypothalamic-pituitary-adrenal (HPA) axis [22].
The HPA axis is regulated by corticotrophin-releasing hor-
mone (Crh) released from neurosecretory cells of the
hypothalamic paraventricular nucleus. Crh stimulates re-
lease of adrenocorticotropic hormone (ACTH) from the
anterior pituitary, and ACTH, in turn, triggers glucocortic-
oid secretion from the adrenal gland. Negative feedback
from ACTH and glucocorticoid secretion ultimately mod-
ulates Crh expression in the paraventricular nucleus via
glucocorticoid receptors [23]. Disrupting glucocorticoid
feedback loops can alter whole-body energy balance (e.g.
body weight). Glucocorticoid excess (Cushing’s disease) in-
creases central fat deposition, whereas decreased body
weight is associated with glucocorticoid insufficiency
(Addison’s disease) [19-21]. In addition to these effects on
metabolism, alterations in the HPA axis can also influence
anxiety and stress, which increase Neuropeptide Y (Npy)
secretion. Npy further augments obesity susceptibility by
inducing food intake and contributing to leptin resistance
[23-25].
Consequently, we propose that Errβ modulates stress re-
sponses. Since Errβ suppresses glucocorticoid receptor ac-
tivity [22], we hypothesized that the HPA axis may be
altered in mice that carry heterozygous or homozygous
loss of function mutations of Errβ in all somatic tissues
[14,26,27]. The effects of Errβ deficiency on body weight,
body composition, neuropeptide levels, stress hormones,
and stress responses were examined in Sox2-Cre:Errβ+/lox
and Sox2-Cre:Errβlox/lox mice, in which Errβ expression is
disrupted in all somatic tissues. These results indicate that
Errβ modulates stress responses, at least in part through
central mechanisms.
Results
Errβ gene dosage alters body weight and body
composition
Sox2-Cre:Errβ+/lox heterozygous mice express one allele
of Errβ, resulting in higher levels of Errβ expression rela-
tive to Sox2-Cre:Errβlox/lox homozygous mice. Alterations
in energy balance are observed in mice deficient for Errβ
in all embryonic tissues (Sox2-Cre:Errβlox/lox) [14]. BecauseErrβ is proposed to modulate energy balance in a dose-
dependent manner, we characterized Sox2-Cre:Errβlox/lox
and Sox2-Cre:Errβ+/lox mice to determine whether gene
dosage altered development of body weight and body com-
position. We previously showed that Sox2-Cre:Errβlox/lox
mice have decreased body weight and fat mass by nine
months of age [8]. Body weight and body composition (fat
mass and lean mass) were measured in Sox2-Cre:Errβlox/lox,
Sox2-Cre:Errβ+/lox, and WT mice at three weeks and at nine
months of age (Table 1). By three weeks, body composition
differences began to emerge between the genotypes: Sox2-
Cre: Errβ+/lox mice significantly increased fat mass (fat
mass: F1,8 = 9.32, P = 0.05), while Sox2-Cre:Errβ
lox/lox mice
trended toward decreased fat mass (fat mass: F1,10 = 4.95,
P = 0.05) compared to WT mice. There was no difference
in body weight among the genotypes at three weeks, imply-
ing that alterations in body composition arise prior to
weight changes in Errβ-deficient mice.
At nine months of age, Sox2-Cre:Errβ+/lox mice had in-
creased fat mass and no change in lean mass relative to
WT mice (fat mass: F1,9 = 35.90, P = 0.002). However,
Sox2-Cre:Errβlox/lox mice demonstrated the opposite trend
in body composition, with decreases in both fat and lean
mass (fat free mass) relative to WT mice (fat mass: F1,10 =
46.53, P < =0.0001; lean mass: F1,10 = 6.21, P = 0.03). Ac-
cordingly, body weight increased in Sox2-Cre:Errβ+/lox
mice (F1,9 = 32.31, P = < 0.000001) and decreased in Sox2-
Cre:Errβlox/lox mice (F1,10 = 32.57, P = 0.0004) relative to
WT mice. Given these differences, the Sox2-Cre:Errβ+/lox
mice surprisingly had a similar macrostructure of food in-
take as the Sox2-Cre:Errβlox/lox [14], relative to WT mice.
Specifically, after consuming a meal, the duration of time
that the mouse was satiated was decreased (satiety ratio),
the total number of pellets consumed was increased, and
the duration of time between meals (intermeal interval,
IMI) was not changed for Sox2-Cre:Errβ+/lox mice, but IMI
was decreased for Sox2-Cre:Errβlox/lox mice (Table 1). The
difference in IMI between the genotypes may be a com-
pensatory change due to peripheral signals modulated by
the increases in both body weight and fat mass observed
in the Sox2-Cre:Errβ+/lox mice.
Hypothalamic neuropeptide expression in Errβmutant mice
In the brain, Errβ is primarily expressed in the hind-
brain, whereas Errγ is expressed in both the hindbrain
and hypothalamus [14,28,29]. Nuclei of the hindbrain
send primary projections to the hypothalamus (e.g., nu-
cleus tractus solitarius to the paraventricular nucleus)
and the amygdala, and activity in these nuclei can modu-
late hypothalamic gene expression [30-32]. Furthermore,
in the absence of Errβ, Errγ can modulate food intake
[14]. Since Sox2-Cre:Errβ+/lox and Sox2-Cre:Errβlox/lox mice
demonstrated alterations in body weight and body com-
position relative to WT mice, we sought to determine if
Table 1 Body weight and body composition, physical activity and meal patterns of wild type (WT), Sox2-Cre:Errβ+/lox,
and Sox2-Cre:Errβlox/lox mice
Genotype Age Body composition Meal patterns
Body weight Fat mass Lean mass Activity Pellets Satiety ratio IMI
(grams) (grams) (grams) (beam breaks) (number) (IMI/meal size) (minutes)
WT 3 weeks 13.1 ± 0.5 2.09 ± 0.09 10.06 ± 0.41
Sox2-Cre:Errβ+/lox 3 weeks 14.0 ± 0.7 2.58 ± 0.16* 10.56 ± 0.62*
Sox2-Cre:Errβlox/lox 3 weeks 12.9 ± 0.8 1.64 ± 0.17 10.51 ± 0.61
WT 9 months 36.5 ± 0.9 12.19 ± 0.65 23.09 ± 0.46 67207 ± 8601 128 ± 15 8.3 ± 0.9 107 ± 17
Sox2-Cre:Errβ+/lox 9 months 46.1 ± 3.0* 21.43 ± 1.84* 24.00 ± 0.63 93599 ± 9879 238 ± 35* 5.6 ± 0.7# 102 ± 10
Sox2-Cre:Errβlox/lox 9 months 28.4 ± 1.3* 5.69 ± 0.74* 21.64 ± 0.40* 133741 ± 20533* 260 ± 57* 4.1 ± 0.7* 67 ± 11*
*P < 0.05 relative to WT.
#P = 0.05 relative to WT.
Activity is a measurement for the number of beam break, which represents horizontal physical activity that is parallel to the ground.
Meal patterns for Sox2-Cre:Errβlox/lox mice are adapted from [14].
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balance, Npy and Agrp, were differentially expressed in the
brains of these mutants. Brain tissue sections of three-
week-old WT, Sox2-Cre:Errβ+/lox, and Sox2-Cre:Errβlox/lox
mice were hybridized with cRNA probes specific to Npy
and Agrp mRNA. Npy (Figure 1a) and Agrp (Figure 1b)
staining were least intense in the hypothalamus of WT
brain tissues, more intense in Sox2-Cre:Errβ+/lox brain tis-
sues, and most intense in Sox2-Cre:Errβlox/lox brain tissues.
Expression of Npy and Agrp, as determined by hypothal-
amic ISH staining, appears to correlate inversely with Errβ
expression. Increased staining expression of Npy and Agrp
may contribute to the increased fat mass of three-week
-old Sox2-Cre:Errβ+/lox mice; conversely, the high levels of
Npy and Agrp in Sox2-Cre:Errβlox/lox mice may be a down-
stream response to decreased fat mass.
Sox2-Cre:Errβlox/lox mice show elevated activity levels
due to defects in vestibular system development [14,26],
which likely contribute to the body weight and bodyFigure 1 Hypothalamic neuropeptide expression in wild-type (WT), So
were harvested from three-week-old WT, Sox2-Cre:Errβ+/lox, and Sox2-Cre:Err
probes to a) Npy and b) Agrp (n = 3/genotype).composition differences observed at nine months of age.
However, three-week-old Sox2-Cre:Errβ+/lox mice are not
hyperactive, suggesting that activity alone does not control
hypothalamic neuropeptide levels (Table 1: Sox2-Cre:
Errβlox/lox vs. WT - F1,9 = 16.43, P = 0.004).
Errβ gene dosage alters expression of HPA axis
components
Errβ interacts with glucocorticoid receptors in neuro-
blastoma and kidney cells [22,33] and may also interact
in the hindbrain where Errβ is expressed [14]. Since in-
creased Npy expression is often associated with elevated
levels of glucocorticoid release, which can influence adi-
posity [23-25], we hypothesized that Errβ deficiency may
alter stress responsiveness via glucocorticoid secretion.
Therefore, stress responses of WT, Sox2-Cre:Errβ+/lox, and
Sox2-Cre:Errβlox/lox mice were measured by detecting al-
terations in HPA axis components, Crh expression and
corticosterone.x2-Cre:Errβ+/lox, and Sox2-Cre:Errβlox/lox mouse brains. Brain tissues
βlox/lox mice; frozen tissue sections were hybridized in situ with cRNA
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deficiency, stress responses were investigated in the pres-
ence of synthetic agonists of Errγ. Atlhough agonists spe-
cific to individual Err isoforms are not commercially
available, we were able to perform these studies using
DY131, a selective agonist of both Errβ and Errγ [34]. It
has been previously determined that DY131 is able to
readily penetrate the blood–brain barrier, as it is both
hydrophobic and has a topological surface area (TPSA)
less than 70 [14]. In Sox2-Cre: Errβlox/lox null mice, DY131
would exclusively activate Errγ and that this would result
in alterations in HPA axis function (e.g. Crh expression or
corticosterone levels). We utilized a restraint stress para-
digm to measure corticosterone serum levels during base-
line, stress, and recovery phases. WT mice demonstrated
increased stress-induced corticosterone levels, which
returned to baseline after one hour of recovery (Figure 2a)
(baseline vs. stress: F1,8 = 7.82, P = 0.03). Similar results
were measured in WT mice administered DY131 (DY131
WT, baseline vs stress: F1,8 = 6.46, P = 0.03; control WT;
DY131 WT, stress vs recovery: F1,11 = 8.54, P = 0.01). Sox2-
Cre:Errβ+/lox mice exhibited markedly elevated cortico-
sterone levels during stress, which may arise from altered
negative feedback mechanisms that modulate cortico-
sterone secretion (e.g. enhanced Crh secretion from the
brain). Sox2-Cre:Errβ+/lox mice exhibit normal recovery to
baseline one hour after the stress test (Figure 2b – control
Sox2-Cre:Errβ+/lox, baseline vs stress: F1,14 = 8.62, P = 0.01).
Administration of DY131 yielded similar results (DY131
Sox2-Cre:Errβ+/lox, baseline vs stress: F1,14 = 7.02, P = 0.02;
control Sox2-Cre:Errβ+/lox, stress vs recovery: F1,14 = 7.14,
P = 0.02; DY131 Sox2-Cre:Errβ+/lox, stress vs recovery:
F1,14 = 8.83, P = 0.01).Figure 2 Glucocorticoid levels of wild-type (WT), Sox2-Cre:Errβ+/lox, an
and recovery glucocorticoid levels were measured in serum of WT mice an
radioimmunoassay. b) Baseline, stress, and recovery glucocorticoid levels w
with Errβ/Errγ agonist DY131 using a corticosterone radioimmunoassay. c)
serum of Sox2-Cre:Errβlox/lox mice and after treatment with Errβ/Errγ agonistIn contrast, Sox2-Cre:Errβlox/lox mice had elevated base-
line corticosterone levels but exhibited no increase with
stress (Figure 2c – control Sox2-Cre:Errβlox/lox, baseline vs
stress: F1,8 = 10.86, P = 0.02; DY131 Sox2-Cre:Errβ
lox/lox,
baseline vs stress: F1,8 = 15.14, P = 0.01; control Sox2-Cre:
Errβlox/lox; DY131 Sox2-Cre:Errβlox/lox, baseline vs recov-
ery: F1,8 = 21.81, P = 0.01), suggesting that Errβ:Sox2-
Crelox/lox mice are unable to increase corticosterone levels
in response to restraint stress. In fact, expression of Crh,
as determined by ISH staining, was increased in the Sox2-
Cre:Errβlox/lox mice under baseline conditions, a modest
increase in ISH staining was also seen in the Sox2-Cre:
Errβ+/lox mice, with DY131 further increasing the ISH
staining for Crh. This data suggests that Errγ may modu-
late expression of Crh in a manner dependent on the level
of Errβ expression (Figure 3).
Neural progenitor-specific deletion of Errβ alters acoustic
startle response
Sox2-Cre:Errβ+/lox and Sox2-Cre:Errβlox/lox mice demon-
strate differences in HPA activation, which may arise from
central and/or peripheral mechanisms. In the central ner-
vous system, Errβ expression is restricted to the hindbrain.
Nes-Cre:Errβlox/lox mice lack Errβ in neural progenitor
cells, effectively resulting in selective loss of Errβ expres-
sion in the hindbrain [14]. Therefore, we investigated the
central role of Errβ in modulating stress responses in Nes-
Cre:Errβlox/lox and WT mice using an acoustic startle test.
The neuroanatomical and neurochemical basis of the
acoustic startle response has been well mapped and in-
volves neurons found in the amygdala, dorsomedial hypo-
thalamus, and brainstem [35-39]. The amygdala elicits
behavioral stress responses associated with the acousticd Sox2-Cre:Errβlox/lox mice after restraint stress. a) Baseline, stress,
d after treatment with Errβ/Errγ agonist DY131 using a corticosterone
ere measured in serum of Sox2-Cre:Errβ+/lox mice and after treatment
Baseline, stress, and recovery glucocorticoid levels were measured in
DY131 using a corticosterone radioimmunoassay. *P < 0.05.
Figure 3 Crh expression of wild-type (WT), Sox2-Cre:Errβ+/lox, and Sox2-Cre:Errβlox/lox mice. Brain tissue of WT, Sox2-Cre:Errβ+/lox, and Sox2-
Cre:Errβlox/lox mice injected with saline (top) or Errβ/Errγ agonist DY131 (bottom) were stained for Crh by ISH (n = 2/genotype).
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and Npy [36,40]. Nes-Cre:Errβlox/lox mice have decreased
Npy expression in the hindbrain [14], which may modify
neural circuitry activated by physical and psychological
stress and, more specifically, the acoustic startle response.
We measured PPI and the acoustic startle response to
determine if Nes-Cre:Errβlox/lox mice had alterations in
stress responses that arise from dysfunction of the in-
hibitory hindbrain circuit associated with PPI or the ex-
citatory circuit associated with the acoustic startle
response [41]. The acoustic startle response was measured
after delivery of a prepulse intensity signal (0, 74, 78, 82, 86,
or 90 dB) followed by the lead interval to a strong auditory
stimulus. We observed a greater startle response in Nes-
Cre:Errβlox/lox mice (n = 8, db120; 1081.5 ±150) compared
to WT mice (n = 12, db120; 475.8 ± 27) (Figure 4a, 0db -
F1,20 = 0.05, P = 0.81; 0-120db - F1,20 = 9.25, P = 0.006; 74-
120db - F1,20 = 15.13, P = 0.001; 78-120db - F1,20 = 15.63,
P = 0.0009; 82-120db - F1,20 = 14.04, P = 0.001; 86-120db -
F1,10 = 14.17, P = 0.001; 90-120db - F1,8 = 14.98, P = 0.001).
However, the amplitude of the startle response decreased in
Nes-Cre:Errβlox/lox mice when the intensity of the prepulse
tone increased. Crh expression was measured in the hind-
brain of Nes-Cre:Errβlox/lox mice and WT mice. Indeed,
Nes-Cre:Errβlox/lox mice have decreased expression of Crh
and Crhr2 relative to WT (Figure 4b, F1,10 = 6.54, P = 0.03
and Figure 4c, F1,10 = 6.23, P = 0.03). These results indicate
alterations in the excitatory pathway that generates a startle
response, but not the inhibitory pathway arising from the
pedunculopontine tegmental nucleus associated with PPI
[41-43]. The increased acoustic startle response in Nes-Cre:
Errβlox/lox mice may thus arise from altered activity of the
excitatory pathway involving Crh and Crhr2 expression and
the pontine reticular nucleus, bed nucleus of the stria
terminalis, amygdala, and hypothalamus [37-39,43-48].
The hindbrain excitatory pathways, which includecatecholaminergic projections to the paraventricular
nucleus of the hypothalamus, increase Crh expression
in the hypothalamus, suggesting that hindbrain signal-
ing may alter the HPA-axis feedback loop [49].
Discussion
ERRs are involved with energy balance and metabolism
[14-18]. Using mice globally deficient for Errβ, we have
shown that Errβ modulates body composition, stress
signaling, and hypothalamic neuropeptide expression
(Table 2). Errβ gene dosage affected body composition and
stress response with increased fat mass and corticosterone
levels in Sox2-Cre:Errβ+/lox mice and decreased fat mass
and corticosterone levels in Sox2-Cre:Errβlox/lox mice
(Table 1 and Figure 2). Additionally, central nervous
system-specific Errβ deletion alters stress associated with
the acoustic startle response pathways (Figure 4).
Hypothalamic expression of Npy and Agrp, orexigenic
factors that increase fat mass and food intake [50-52],
increased in both Sox2-Cre:Errβ+/lox and Sox2-Cre:
Errβlox/lox mice (Figure 1). These results suggest that in-
creased anabolic neuropeptide expression may be due to
central or peripheral mechanisms that are activated fol-
lowing global deletion of Errβ. Increased Npy and Agrp
expression may be due to differences in leptin levels from
adipose mass. Increased fat mass and lean mass were mea-
sured in Sox2-Cre:Errβ+/lox mice, although decreased fat
mass and lean mass were measured in highly-active Sox2-
Cre:Errβlox/lox mice at nine months of age (Table 1). Expres-
sion of Npy and leptin are coordinately regulated, as Npy
blunts the effects of leptin and increased leptin levels de-
crease Npy expression [23,53-55]. Thus, Sox2-Cre:Errβ+/lox
mice may consume more food and increase Npy expression
and fat mass due to leptin resistance; Sox2-Cre:Errβlox/lox
mice may increase Npy expression to compensate for de-
creased fat mass arising from increased physical activity
Figure 4 Acoustic startle response, pre-pulse inhibition (PPI)
and Crhr2 expression for wild-type (WT) and Nes-Cre:Errβlox/lox
mice. a) The force elicited by the acoustic startle response was
measured from WT and Nes-Cre:Errβlox/lox mice after pre-pulse
inhibition over five different acoustic intensities (74, 78, 82, 86, and
90 dB). b) Crh and c) Crhr2 levels were decreased in the hindbrain of
Nes-Cre:Errβlox/lox mice, relative to WT. Data shown are mean ± SEM
for each group. *P < 0.05.
Table 2 Summary of phenotype difference between Sox2-
Cre:Errβ+/lox, Sox2-Cre:Errβlox/lox and Nes2-Cre:Errβlox/lox








Body weight ↑, ↓, ↑
Fat mass ↑, ↓, NC
Lean mass ↓, ↓, ↑
Hormone and Neuropeptides
Corticosterone ↑, ↓, NA
Corticosterone (DY131) ↑, ↓, NA
Crh expression ↑, ↑, ↓
Crh expression (DY131) ↑↑, ↑↑, NA
Npy expression ↑, ↑, ↓
Agrp expression ↑, ↑, NA
Stress Behavior
Acoustic startle response NA, NA, ↑
Meal patterns
Total pellets consumed ↑, ↑, NC
Inter Meal interval (IMI) NC, ↓, ↓
Satiety Ratio ↓#, ↓, ↓
↑ – increase, ↓ – decrease, NC – no change, ↑↑ – increase relative to levels
with no DY131 treatment, NA – not available, #P = 0.05 relative to WT; Nes2-
Cre:Errβlox/lox data adapted from [14].
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mice have increased lean mass, no change in physical activ-
ity and have decreased Npy expression in the hindbrain
[14]. Changes in body composition emerged prior to
changes in body weight, suggesting that both peripheral and
central signals may be altered to regulate the development
of increased fat mass (Table 1).
The opposite phenotypes that are seen in the Sox2-Cre:
Errβ+/lox and Sox2-Cre:Errβlox/lox mice may arise from the
ability of Errβ or Errγ to regulate gene transcription as
both homodimers and Errβ/Errγ heterodimers [1,6,7,9,10].
Errβ/Errγ heterodimers have been predicted to exist, but
to our knowledge it has not been directly detected in vivo
[1]. RIP140 is a nuclear receptor corepressor that regulates
cellular metabolism [56-58]. RIP140 enhanced transcrip-
tional activity for all three mouse Err genes [59]. Micelacking RIP140 are lean, with increased metabolic rate and
insulin sensitivity [58]. Similarly, Sox2-Cre:Errβlox/lox mice
are lean with increased metabolic rate (Table 1 and [14]),
and Nes-Cre:Errβlox/lox have increased lean mass, increased
metabolic rate and insulin sensitivity [14]. Since deletion
of both Errβ and RIP140 exhibit similar phenotypes, this
suggests that increased lean mass relative to fat mass,
metabolic rate and insulin sensitivity may arise from both
the RIP140 corepressor and Errβ [59].
ChIP-seq analysis derived from embryonic stem cells
revealed that Errβ binds the regulatory element of two
genes associated with Crh activity — Corticotropin re-
leasing hormone binding protein (Crhbp) and Cortico-
tropin releasing hormone receptor 2 (Crhr2) — as well
as one gene associated with whole-body energy balance
and stress responses, Cholecystokinin B receptor
(Cckbr) [60]. We hypothesize that Errβ, Crhbp and
Crhr2 may modulate stress signaling by altering the bio-
logical activity of Crh in extrahypothalamic sites and/or
corticosterone feedback or secretion [32,39,48,61-64].
Disruption of Errβ-dependent regulation of expression
of Cckbr and/or Crhr2 may at least partially explain the
abnormal meal patterns and stress behaviors (e.g.
acoustic startle response, Crh expression or cortico-
sterone levels) observed in Sox2-Cre:Errβlox/lox, Sox2-
Cre:Errβ+/lox, and Nes-Cre:Errβlox/lox mice [14].
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hypothalamus and initiates ACTH release from the pituit-
ary [40,65]. Crh has since been found to be synthesized in
extra-hypothalamic sites, where it also acts to modulate
stress response and food intake [40,65-67]. ERR family
members also modulate stress responses by regulating
glucocorticoid receptor activity in muscle and neuroblast-
oma cell lines [22,33]. Further, Errβ and Crh are expressed
in similar regions of the hindbrain [29]. Here we demon-
strate that Errβ deletion modulates corticosterone levels
after exposure to restraint stress, with increased levels in
Sox2-Cre:Errβ+/lox mice and decreased levels in Sox2-Cre:
Errβlox/lox mice relative to WT (Figure 2). Neural connec-
tions projecting to the hypothalamus from extra-
hypothalamic sites, such as the hindbrain, may also
regulate hypothalamic Crh release and Crh expression
[30,49,68-70].
Biological activity of Crh is inhibited by Crhbp, and
Errβ binds to the promoter region of the Crhbp gene
[60,71], which contains three ERE half sites [72]. Mice
that overexpress Crhbp have increased Crh expression,
potentially resulting from a compensatory response
aimed at ameliorating disruptions in stress response
[73]. Similarly, increased Crh expression was observed
when Errβ was reduced (Sox2-Cre:Errβ+/lox) or elimi-
nated (Sox2-Cre:Errβ+/lox) in somatic tissue, and Errγ
was activated using DY131 (Figure 3). Therefore, we
propose that partial or complete deletion of Errβ may
alter Crh expression by modulating transcription of
Crhbp or Crhr2, resulting in altered corticosterone se-
cretion. Furthermore, Sox2:Errβlox/lox mice lack cortico-
sterone secretion after restraint stress (Figure 2), which
may result from altered Crhr2 expression (Figure 4c)
and changes in negative feedback. Therefore, brain re-
gions that express Crhr2 may show reduced Crh signal-
ing (Figure 4b and 4c), as in the hindbrain [64].
Errβ binds to cis-regulatory regions of the Cckbr gene
[60], which is expressed in the hindbrain [29,74] and the
corresponding gene maps to a genomic locus of the gen-
ome associated with obesity [75]. Cckbr deficient mice
(Cckbr−/−) display a similar phenotype to Sox2-Cre:
Errβ+/lox mice, and have increased body weight and food
intake, which may arise from changes in Cholecystokinin
(Cck) signaling (e.g. satiety), and increased metabolism
[74,76]. However, Cckbr−/− mice also have blunted stress
responses associated with anxiety-like behavior [77] and
increased Npy expression [78], which resembles the
phenotype of Sox2-Cre:Errβlox/lox mice (Figure 1 and
Table 1). Therefore, heterodimers of Errβ alone, or Errβ
in combination with ERRγ, may regulate Cckbr tran-
scription, thereby partially accounting for the differences
in the phenotypes seen in Sox2-Cre:Errβ+/lox and Sox2-
Cre:Errβlox/lox mice (Table 2). Differences in develop-
mental compensation arising from Errβ and/or Errγ mayalso contribute to the phenotype differences in Sox2-Cre:
Errβ+/lox and Sox2-Cre:Errβlox/lox mice.
Nes-Cre:Errβlox/lox mice show increased Errγ expression
relative to WT animals [14], while mice deficient for Errγ
show increased Errβ expression [17]. This suggests that
homozygous mice have reciprocal patterns of Errβ and Errγ
expression, potentially arising from developmental com-
pensation and heterozygous mice may partially lack this
compensation, contributing to phenotype differences. The
Errβ/Errγ agonist (DY131) increased Crh expression more
when Errβ expression was reduced (Sox2:Errβ+/lox mice)
than when Errβ expression was absent (Sox2:Errβlox/lox
mice) (Figure 3). These results suggest that the ratio of Errβ
to Errγ signaling may contribute to the observed difference
in Crh expression, Crhr2 expression and corticosterone se-
cretion in the two genotypes examined.
Sox2-Cre:Errβlox/lox and Sox2-Cre:Errβ+/lox mice have al-
terations in the HPA axis (Figures 2 and 3). Npy, which
modulates corticosterone levels [79], is altered in Sox2-
Cre:Errβ+/lox and Sox2-Cre:Errβlox/lox (Figures 1 and 2).
Both Crh and Npy have been implicated in modulating
the acoustic startle response [32,36,40,80], which is altered
in Nes-Cre:Errβlox/lox mice (Figure 4 and [14]). Given the
results reported here, the phenotype differences between
Sox2-Cre:Errβ+/lox and Sox2-Cre:Errβlox/lox mice may spe-
cifically arise from altered Crh expression and cortico-
sterone levels as a result of changes in Errβ-dependent
regulation of Crhbp or Crhr2 transcription, as well as
through interactions of Errβ with Errγ. However, since lit-
tle is known about Errβ/Errγ heterodimers or how differ-
ent Err family homo and heterodimers may potentially
regulate Crhbp or Crhr2 transcription deserves further
investigation.
Our data suggest that central Errβ modulates stress re-
sponses, food intake and body weight, although it remains
to be determined whether peripheral Errβ also modulates
components of the HPA axis and acoustic startle response.
Nes-Cre:Errβlox/lox mice lack Errβ in the hindbrain and
have decreased expression of Crh, Crhr2 and Npy [14],
suggesting that neuromodulators involved with the acous-
tic startle response reside in the hindbrain to modulate
stress and anxiety. However, other changes in neural cir-
cuitry (e.g. altered Cckbr expression) regulating the acous-
tic startle response in Nes-Cre:Errβlox/lox mice are likely to
exist and remain to be identified.
Conclusions
Mice heterozygous for Errβ deletion have increased fat
mass and stress hormone secretion after restraint stress,
while those homozygous for Errβ deletion have decreased
fat mass and secrete higher baseline levels of stress hor-
mones. These effects may be modulated by components
of the HPA axis, such as Crh, Crhbp, Crhr2, Npy or Cckrb.
Central Errβ signaling influences stress associated
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through regulation of Npy, Crh and Crhr2 expression in
the hindbrain or hypothalamic projections to the amyg-
dala [32,62,63,80]. Since the neural circuitry controlling
the acoustic startle response is well-conserved between ro-
dents and humans [36,81], these data suggest that ERRβ
or ERRγ may be promising candidates for pharmacological
treatment of excessive anxiety or stress levels in humans.
Methods
Animals, housing, food intake, and physical activity
measurement
Sox2-Cre:Errβlox/lox, Sox2-Cre:Errβ+/lox, and wild-type
(WT) (Errβlox/lox) mice were generated as previously de-
scribed [26]. Briefly, Errβ mice have a conditional allele,
with loxP sites flanking exon 2 of the Errβ gene that en-
codes the DNA binding domain (exon 2) [26]. Expres-
sion of cre recombinase will excise the loxP-flanked
exon 2 from the Errβ gene. Sox2-Cre deletes Errβ from
all embryonic tissues and Nestin-Cre deletes Errβ from
developing neural tissue. Sox2-Cre:Errβlox/lox mice com-
pletely lack functional Errβ because both alleles have
been removed. Sox2-Cre:Errβ+/lox have one wild-type al-
lele of the Errβ gene, since the other allele has been ex-
cised by the loxP sites. These two mouse lines enable us
to address possible phenotypic differences due to differ-
ences in gene dosage. Wild-type (WT) mice used for
these studies were homozygous for the floxed Errβ allele.
Mice were maintained on a 12:12 hour light–dark cycle
in a temperature- and humidity-regulated vivarium and
had ad libitum access to standard laboratory chow
(2018, Harlan-Teklad, Harlan Laboratories, Frederick,
MD, USA) and water at all times. Different cohorts of
mice were analyzed at three weeks and nine months of
age. Food intake data and physical activity levels were col-
lected as previously described [14]. Physical activity levels
were measured by detecting and counting horizontal beam
breaks in a 40 cm × 40 cm × 30 cm plexiglass chamber
(Digiscan, Accuscan Instruments, Columbus, OH). All ex-
perimental procedures were performed in accordance
with the Johns Hopkins University School of Medicine
Institutional Animal Care and Use Committee and the
National Institutes of Health Guide for the Care and
Use of Laboratory Animals.
In situ hybridization assay (ISH) and quantitative
real-time PCR
ISH was performed as previously described [14,82]. Briefly,
digoxigenin cRNA probes to Npy and agouti-related protein
(Agrp) were synthesized using the Brain Molecular Anat-
omy Project (BMAP) library containing sequence-verified
expressed sequence tags. BMAP clones were purified using
a PureLink plasmid miniprep kit per manufacturer’s proto-
col (Invitrogen, Carlsbad, CA, USA) and synthesized usinga T3 or T7 RNA polymerase (Roche, Indianapolis, IN,
USA). The riboprobe was purified using an RNA extraction
kit per manufacturer’s protocol (RNeasy, Qiagen, Valencia,
CA, USA). Brains were collected from mice, fresh frozen in
OCT compound (Tissue Tek, Fisher Scientific, Pittsburgh,
PA, USA), and cut using a cryostat into 25-μm sections
onto Superfrost Plus slides (Fisher Scientific, Pittsburgh,
PA, USA). Hindbrain dissection, mRNA extraction and
quantitative real-time PCR was conducted as previously
described [14,83]. Briefly, RNA was extracted (RNeasy,
Qiagen, Valencia, CA, USA) and cDNA was synthesized
using 1 μg of mRNA using Superscript II reverse tran-
scriptase (Invitrogen) and random primers (Invitrogen).
Quantitative PCR primer sequences were obtained from
PrimerBank and conducted for Crh: fwd – 5’ CCTCAGC
CGGTTCTGATCC 3’ and rev – 5’ GCGGAAAAAGTTA
GCCGCAG 3’, Crhr2: fwd – 5’ CATCCACCACGTCCGA
GAC 3’ and rev – 5’ CTCGCCAGGATTGACAAAGAA
3’ and 18S fwd – 5’ GCAATTATTCCCCATGAACG 3’
and rev- 5’ GGCCTCACTAAACCATCCAA 3’. The Ct
value generated was normalized to 18S in order to ob-
tain a ΔCt value, followed by generating the 2-ΔΔCt value
by normalizing the data to control animals as previously
described [84].
Restraint stress test, corticosterone radioimmunoassay,
and DY131 injections
Baseline blood glucocorticoid levels were measured and
mice were placed into a restraining tube (one mouse/tube)
for one hour. Upon removal from the restraining tube,
blood samples were collected again. Animals were then
returned to their housing and blood samples were collected
after a one-hour recovery period. Blood was collected in
heparin-coated tubes and centrifuged at 3800 rpm for
20 min at 4°C. Corticosterone assays were performed with
a radioimmunoassay kit for corticosterone per manufac-
turer’s directions (MP Biomedicals, Solon, OH, USA).
DY131 (Tocris, Bristol, BS11, United Kingdom) at a dose of
10 μM/g body weight was injected, and data for meal pat-
terns collected as previously described [14].
Prepulse inhibition (PPI) of acoustic startle response
Startle reactivity and PPI were measured using two startle
chambers located inside a sound-attenuating chamber
(San Diego Instruments, San Diego, CA, USA). Mice were
placed in a Plexiglass tube within the soundproof PPI box
for a five-minute acclimation period, which provides ex-
posure to a continuous background noise (70 dB) to elicit
an increase in startle amplitude [43]. Mice were then ex-
posed for five minutes without any startle stimulus. The
PPI session then began and mice were randomly exposed
to the following trials: pulse alone (120 dB), no stimulus,
or five prepulse combinations (a 20 ms non-startling
prepulse at 74, 78, 82, 86, or 90 dB, followed by an 80 ms
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tion was recorded by an accelerometer with SR-LAB soft-
ware (San Diego Instruments). Results were analyzed by
PPI percentage, which was calculated as:
mean startle amplitude on pulse aloneð Þ−
mean startle amplitude on prepulseð Þ=
mean startle amplitude on pulse aloneð Þ:
Statistical analysis
All value comparisons were made using one-way
ANOVA to identify individual differences between
groups, and P < 0.05 was considered significant
(Statistica v.8.0, Tulsa, OK, USA).
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